Abstract
Haemofiltration is a popular technique for removal of fluid and small to medium size molecules in critically ill patients. Whilst there is often good information on drug disposition in chronic renal failure, there is a lack of information available to guide Intensivists on how to prescribe drugs in patients in acute renal failure undergoing haemofiltration or haemodiafiltration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
White LO, Bower H, McMullin C, Lovering AM (1989) The therapeutic monitoring of 4-equinolone antibacterials with special reference to ciprofloxacin. International Telesymposium on Quinolones. Fernandes PB, Prous JR, Barcelona, Spain 351–367
Bickley SK (1988) Drug dosing during continuous arteriovenous haemofiltration. Clin Pharm 7:198–302
King A, Phillips I (1986) The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother 18 [Suppl D] 1–20
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barrie, J.R., Mousdale, S. Ciprofloxacin levels in a patient undergoing veno-venous haemodiafiltration. Intensive Care Med 18, 437–438 (1992). https://doi.org/10.1007/BF01694350
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01694350